secwatch.observer — SEC 8-K summary
======================================

Issuer:     TRANSUITE.ORG INC. (TRSO)
CIK:        0001758699
Form:       8-K
Filed at:   2025-10-06T23:59:59+00:00
Accession:  0001640334-25-001779
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRSO acquires 100% of AI TCM firm XRS for 10M restricted shares plus earnout
----------------------------------------------------------------------------

- TRSO issued 10M restricted shares to Hailiang Li for 100% of XRS; earnout may add shares based on 90-day valuation.
- XRS combines AI social agents with Traditional Chinese Medicine; owns 300 proprietary TCM e-books and a 21-day health supervision system.
- Acquisition closed Sept 30, 2025; TRSO expands into AI-powered healthcare and TCM sectors.
- CEO Mengqing Fan says the deal will integrate AI and blockchain to globalize TCM products.
- XRS CEO Hailiang Li expects TRSO's technology to enhance product intelligence and global expansion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1758699/000164033425001779/0001640334-25-001779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1758699/000164033425001779/trso_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-001779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer